Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-004325
Filing Date
2019-01-17
Accepted
2019-01-17 17:32:00
Documents
1
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7819
  Complete submission text file 0001209191-19-004325.txt   9403
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1522 217TH PLACE SE SUITE 100 BOTHELL WA 98021
Business Address
JACOBS CINDY (Reporting) CIK: 0001229762 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 19531649